The survival of patients with bronchial asthma is related to their degree of control of the disease. Patients with strictly controlled disease do not differ from normal people in terms of life expectancy, while in those with poor control, the disease progresses more rapidly and can affect survival. Bronchial asthma is a chronic disease for which there is no cure, but only respiratory management to reduce the number of asthma attacks and to delay and control the progression of the lung disease. If patients can take their medication regularly and avoid the factors that cause asthma in their daily life, they can obtain the same life expectancy as normal people and have no major impact on their daily life. However, if patients are unable to perform effective control, reversible obstruction of the bronchial tubes will become irreversible lesions, leading to chronic obstructive disease, and survival can be significantly shortened and quality of life will be reduced. In conclusion, the treatment plan of bronchial asthma should be based on the graded and reasonable choice of medication according to the patient’s condition, and should not be delayed by listening to biased prescriptions.